PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1449604
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1449604
Global myomectomy market size is expected to reach US$ 1,600.9 Mn by 2031, from US$ 791.2 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 9.2% during the forecast period (2024-2031).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2023/2024: | US$ 791.2 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 - 2031 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 9.20% | 2030/2031 Value Projection: | US$ 1,600.9 Mn |
A myomectomy is a surgical treatment that is used to remove noncancerous growths called uterine fibroids that grow in the uterus's muscular wall. Numerous symptoms, including pelvic pain, excessive monthly flow, and problems with fertility, can be brought on by these fibroids.
A myomectomy is a surgical procedure designed to specifically target and remove fibroids while preserving the integrity of the uterus. This is in contrast to a hysterectomy, where the entire uterus is removed. This makes myomectomy a reasonable alternative for women who prefer to keep their fertility or avoid the psychological and physiological impacts of a complete uterine removal. Depending on the quantity, location, and size of fibroids, the surgery can be carried out by using an abdominal, laparoscopic, or hysteroscopy method. For women with fibroid-related problems, a myomectomy can reduce symptoms and enhance the quality of their reproductive experience.
The myomectomy market is influenced by various dynamic factors. Increasing prevalence of uterine fibroids among women globally propels the market growth. Technological advancements in surgical techniques, such as the evolution of minimally invasive procedures like laparoscopic and hysteroscopic myomectomy, contribute to the expanding market. Growing awareness about women's health and fertility issues also drives demand for myomectomy procedures. Changing demographics, delayed pregnancies, and lifestyle factors impacting women's health contribute to the market's dynamics. Rise in healthcare expenditure, particularly in developed regions, supports the adoption of myomectomy procedures.